Implantable Drug Delivery Systems

[1]  Jagdish Singh,et al.  In vivo absorption of steroidal hormones from smart polymer based delivery systems. , 2010, Journal of pharmaceutical sciences.

[2]  A. Shukla,et al.  Controlled Release of Contraceptive Steroids from Biodegradable and Injectable Gel Formulations: In Vivo Evaluation , 1995, Pharmaceutical Research.

[3]  K. Peck,et al.  Development of an in situ forming biodegradable poly-lactide-coglycolide system for the controlled release of proteins , 1995 .

[4]  R. Langer,et al.  Polymers for the controlled release of macromolecules: effect of molecular weight of ethylene-vinyl acetate copolymer. , 1985, Journal of biomedical materials research.

[5]  A. McHugh,et al.  Role of crystallization in the phase inversion dynamics and protein release kinetics of injectable drug delivery systems. , 2001, Journal of controlled release : official journal of the Controlled Release Society.

[6]  T. A. Hatton,et al.  Poly(ethylene oxide)-poly(propylene oxide )-poly (ethylene oxide) block copolymer surfactants in aqueous solutions and at interfaces: thermodynamics, structure, dynamics, and modeling , 1995 .

[7]  Antonio M. Rabasco,et al.  Percolation theory : application to the study of the release behaviour from inert matrix systems , 1993 .

[8]  J. Folkman,et al.  THE USE OF SILICONE RUBBER AS A CARRIER FOR PROLONGED DRUG THERAPY. , 1964, The Journal of surgical research.

[9]  Himanshu K. Solanki,et al.  RECENT ADVANCES IN IMPLANTABLE DRUG DELIVERY , 2010 .

[10]  J. Cleland,et al.  Sustained delivery of human growth hormone from a novel gel system: SABER. , 2002, Biomaterials.

[11]  Y. Ogura,et al.  Intraocular tissue distribution of betamethasone after intrascleral administration using a non-biodegradable sustained drug delivery device. , 2003, Investigative ophthalmology & visual science.

[12]  Sunil B Jaiswal,et al.  A flexible technology for modified-release drugs: multiple-unit pellet system (MUPS). , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[13]  N. Peppas,et al.  [Relation between the structure of polymers and the controlled release of active ingredients]. , 1983, Pharmaceutica acta Helvetiae.

[14]  O. Sartor.  Eligard® 6: A New Form of Treatment for Prostate Cancer , 2006 .

[15]  A. McHugh,et al.  The role of polymer membrane formation in sustained release drug delivery systems. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[16]  T. Kissel,et al.  In situ forming parenteral drug delivery systems: an overview. , 2004, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[17]  Roland Schott,et al.  Retrospective comparison of chemoradiotherapy followed by adjuvant chemotherapy, with or without prior gliadel implantation (carmustine) after initial surgery in patients with newly diagnosed high-grade gliomas. , 2012, International journal of radiation oncology, biology, physics.

[18]  W. Kao,et al.  Drug release kinetics and transport mechanisms of non-degradable and degradable polymeric delivery systems , 2010, Expert opinion on drug delivery.

[19]  S. Gorman,et al.  Controlled release of a model antibacterial drug from a novel self-lubricating silicone biomaterial. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[20]  G. Saidel,et al.  Drug-eluting polymer implants in cancer therapy. , 2008, Expert opinion on drug delivery.

[21]  A. Göpferich,et al.  Polymer Bulk Erosion , 1997 .

[22]  Jin Gao,et al.  Fabrication and characterization of controlled release poly(D,L-lactide-co-glycolide) millirods. , 2001, Journal of biomedical materials research.

[23]  D. Korte,et al.  DEHP‐plasticised PVC: relevance to blood services * , 2011, Transfusion medicine.

[24]  Robert N. Taylor,et al.  Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding. , 2005, The Journal of clinical endocrinology and metabolism.

[25]  O. Sartor.  Eligard: leuprolide acetate in a novel sustained-release delivery system. , 2003, Urology.

[26]  S. Garrett,et al.  The drug delivery and biomaterial attributes of the ATRIGEL technology in the treatment of periodontal disease. , 1998, Expert opinion on investigational drugs.

[27]  Combined modeling and experimental approach for the development of dual-release polymer millirods. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[28]  R. Langer.  Polymer implants for drug delivery in the brain , 1991 .

[29]  I. Fraser,et al.  Implantable contraceptives for women. , 2003, Human reproduction update.

[30]  B Dhillon,et al.  Intravitreal sustained-release ganciclovir implantation to control cytomegalovirus retinitis in AIDS , 1998, International journal of STD & AIDS.

[31]  G. E. Visscher,et al.  Tissue Response to Biodegradable Injectable Microcapsules , 1987, Journal of biomaterials applications.

[32]  G. E. Visscher,et al.  Biodegradation of and tissue reaction to poly(DL-lactide) microcapsules. , 1986, Journal of biomedical materials research.

[33]  H. Paajanen,et al.  Randomized clinical trial of tissue glue versus absorbable sutures for mesh fixation in local anaesthetic Lichtenstein hernia repair , 2011, The British journal of surgery.

[34]  R. Siegel.  Pharmacokinetic transfer functions and generalized clearances , 1986, Journal of Pharmacokinetics and Biopharmaceutics.

[35]  Richard L. Dunn,et al.  Sustained activity and release of leuprolide acetate from an in situ forming polymeric implant , 2000, AAPS PharmSciTech.

[36]  Brent D Weinberg,et al.  Modeling doxorubicin transport to improve intratumoral drug delivery to RF ablated tumors. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[37]  P. D. Graham,et al.  Phase inversion dynamics of PLGA solutions related to drug delivery. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[38]  Jagdish Singh,et al.  Controlled delivery of testosterone from smart polymer solution based systems: in vitro evaluation. , 2005, International journal of pharmaceutics.

[39]  S. Engström,et al.  Phase behaviour of the lidocaine-monoolein-water system , 1992 .

[40]  E. Rozet,et al.  Near infrared and Raman spectroscopy as Process Analytical Technology tools for the manufacturing of silicone-based drug reservoirs. , 2011, Analytica chimica acta.

[41]  Sung Wan Kim,et al.  Biodegradable block copolymers as injectable drug-delivery systems , 1997, Nature.

[42]  Luis Solorio,et al.  Advances in image-guided intratumoral drug delivery techniques. , 2010, Therapeutic delivery.

[43]  Juergen Siepmann,et al.  Modeling of diffusion controlled drug delivery. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[44]  Fung,et al.  Polymeric implants for cancer chemotherapy. , 1997, Advanced drug delivery reviews.

[45]  J. Löfroth,et al.  Cubic Phases as Delivery Systems for Peptide Drugs , 1991 .

[46]  K. Miwa,et al.  Ester Hydrolysis by Poly(Allylamine)s Having Hydrophobic Groups: Catalytic Activity and Substrate Specificity , 1996 .

[47]  Luis Solorio,et al.  Characterization of formulation parameters affecting low molecular weight drug release from in situ forming drug delivery systems. , 2010, Journal of biomedical materials research. Part A.

[48]  G E Visscher,et al.  Effect of particle size on the in vitro and in vivo degradation rates of poly(DL-lactide-co-glycolide) microcapsules. , 1988, Journal of biomedical materials research.

[49]  G E Visscher,et al.  Biodegradation of and tissue reaction to 50:50 poly(DL-lactide-co-glycolide) microcapsules. , 1985, Journal of biomedical materials research.

[50]  Y. Bae,et al.  New biodegradable polymers for injectable drug delivery systems. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[51]  R. Cameron,et al.  The effect of initial polymer morphology on the degradation and drug release from polyglycolide. , 2002, Biomaterials.

[52]  J. Haaga,et al.  Injectable Polymer Depot Combined With Radiofrequency Ablation for Treatment of Experimental Carcinoma in Rat , 2006, Investigative radiology.

[53]  A. Roche,et al.  Organic Chemistry: , 1982, Nature.

[54]  P. I. Lee,et al.  Novel approach to zero-order drug delivery via immobilized nonuniform drug distribution in glassy hydrogels. , 1984, Journal of pharmaceutical sciences.

[55]  J. Hubbell,et al.  Sustained release of human growth hormone from in situ forming hydrogels using self-assembly of fluoroalkyl-ended poly(ethylene glycol). , 2005, Biomaterials.

[56]  Heba A. Gad,et al.  Formulation and Evaluation of PLA and PLGA In Situ Implants Containing Secnidazole and/or Doxycycline for Treatment of Periodontitis , 2008, AAPS PharmSciTech.

[57]  F. Alexis.  Factors affecting the degradation and drug-release mechanism of poly(lactic acid) and poly[(lactic acid)-co-(glycolic acid)] , 2005 .

[58]  M. Klüppel,et al.  Structural dynamics and interfacial properties of filler-reinforced elastomers , 2011, Journal of physics. Condensed matter : an Institute of Physics journal.

[59]  K. Zygourakis,et al.  Diffusion in particles with pores of varying cross-section , 1985 .

[60]  M. R. Pereira,et al.  Polymer–filler interactions and mechanical properties of a polyurethane elastomer , 2000 .

[61]  D. Williams,et al.  Enzyme-accelerated hydrolysis of polyglycolic acid. , 1977, Journal of bioengineering.

[62]  D. Bigner,et al.  Overall survival of newly diagnosed glioblastoma patients receiving carmustine wafers followed by radiation and concurrent temozolomide plus rotational multiagent chemotherapy , 2009, Cancer.

[63]  F Leonard,et al.  Biodegradable poly(lactic acid) polymers. , 1971, Journal of biomedical materials research.

[64]  Xiaofei Ma,et al.  Fabrication and characterization of poly(lactic acid)/acetyl tributyl citrate/carbon black as conductive polymer composites. , 2008, Biomacromolecules.

[65]  A. Göpferich,et al.  Mechanisms of polymer degradation and erosion. , 1996, Biomaterials.

[66]  A. Göpferich,et al.  Why degradable polymers undergo surface erosion or bulk erosion. , 2002, Biomaterials.

[67]  D O Thompson,et al.  Cyclodextrins--enabling excipients: their present and future use in pharmaceuticals. , 1997, Critical reviews in therapeutic drug carrier systems.

[68]  Robert Langer,et al.  Modeling of Polymer Erosion , 1993 .

[69]  Y. Ikada,et al.  Properties and morphology of poly(L-lactide). III. Effects of initial crystallinity on long-termin vitro hydrolysis of high molecular weight poly(L-lactide) film in phosphate-buffered solution , 2000 .

[70]  R. Langer,et al.  Transport rates of proteins in porous materials with known microgeometry. , 1989, Biophysical journal.

[71]  O. Pillai,et al.  Drug delivery: an odyssey of 100 years. , 2001, Current opinion in chemical biology.

[72]  H. Metz,et al.  Non-invasive in vivo evaluation of in situ forming PLGA implants by benchtop magnetic resonance imaging (BT-MRI) and EPR spectroscopy. , 2010, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.

[73]  E. Vasheghani-Farahani,et al.  The effect of additives on naltrexone hydrochloride release and solvent removal rate from an injectable in situ forming PLGA implant , 2006 .

[74]  Xue Shenwu.  Synthesis , characterization , biodegradation , and drug delivery application of biodegradable lactic / glycolic acid polymers . Part II : Biodegradation , 2005 .

[75]  K. Jacobson,et al.  Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. , 1973, Biochimica et biophysica acta.

[76]  K. J. Brodbeck,et al.  Sustained Release of Human Growth Hormone from PLGA Solution Depots , 1999, Pharmaceutical Research.

[77]  Y. Bae,et al.  Drug release from biodegradable injectable thermosensitive hydrogel of PEG-PLGA-PEG triblock copolymers. , 2000, Journal of controlled release : official journal of the Controlled Release Society.

[78]  Kevin E. Healy,et al.  Synthesis and characterization of injectable poly(N-isopropylacrylamide)-based hydrogels that support tissue formation in vitro , 1999 .

[79]  L. Scriven,et al.  Equilibrium bicontinuous structure , 1976, Nature.

[80]  H. Ravivarapu,et al.  Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide. , 2000, International journal of pharmaceutics.

[81]  Luis Solorio,et al.  Effect of injection site on in situ implant formation and drug release in vivo. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[82]  A. Exner,et al.  Enhancement of carboplatin toxicity by Pluronic block copolymers. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[83]  R. Langer.  Polymer-controlled drug delivery systems , 1993 .

[84]  D. Mansour.  The benefits and risks of using a levonorgestrel-releasing intrauterine system for contraception. , 2012, Contraception.

[85]  I. Banerjee,et al.  Sustained release of antibiotic from polyurethane coated implant materials , 2009, Journal of materials science. Materials in medicine.

[86]  BIODEGRADABLE IN-SITU FORMING IMPLANTS AND METHODS OF PRODUCING THE SAME BACKGROUND OF THE INVENTION , 2013 .

[87]  P Nieuwenhuis,et al.  Enzymatic activity toward poly(L-lactic acid) implants. , 1990, Journal of biomedical materials research.

[88]  R. Dendievel,et al.  Filler-filler interactions and viscoelastic behavior of polymer nanocomposites , 2004 .

[89]  Anderson,et al.  Biodegradation and biocompatibility of PLA and PLGA microspheres. , 1997, Advanced drug delivery reviews.

[90]  Luis Solorio,et al.  Effect of cargo properties on in situ forming implant behavior determined by noninvasive ultrasound imaging , 2012, Drug Delivery and Translational Research.

[91]  T. Hashimoto,et al.  Structure factors of dispersible units of carbon black filler in rubbers. , 2005, Langmuir : the ACS journal of surfaces and colloids.

[92]  M. Brandon,et al.  Design of controlled-release formulation for ivermectin using silicone. , 2003, International journal of pharmaceutics.

[93]  I. Sivin.  International experience with NORPLANT and NORPLANT-2 contraceptives. , 1988, Studies in family planning.

[94]  He Zhang,et al.  In vitro and in vivo study of thymosin alpha1 biodegradable in situ forming poly(lactide-co-glycolide) implants. , 2010, International journal of pharmaceutics.

[95]  J. Tamada,et al.  The development of polyanhydrides for drug delivery applications. , 1992, Journal of biomaterials science. Polymer edition.

[96]  A. McHugh,et al.  The dynamics of diffusion and gel growth during nonsolvent-induced phase inversion of polyethersulfone , 1995 .

[97]  R. Gurny,et al.  A viscous bioerodible poly(ortho ester) as a new biomaterial for intraocular application. , 2000, Journal of biomedical materials research.

[98]  C. Hillyer,et al.  2‐(Diethylhexyl)phthalate in blood bags: is this a public health issue? , 2011, Transfusion.

[99]  A. Shukla,et al.  Controlled Release of a Contraceptive Steroid from Biodegradable and Injectable Gel Formulations: In Vitro Evaluation , 2004, Pharmaceutical Research.

[100]  M. Bailly,et al.  Effect of polymer/filler interactions on the structure and rheological properties of ethylene-octene copolymer/nanosilica composites , 2010 .

[101]  G. Pulverer,et al.  Controlled release of antibiotics from biomedical polyurethanes: morphological and structural features. , 1997, Biomaterials.

[102]  Combination of sensitizing pretreatment and radiofrequency tumor ablation: evaluation in rat model. , 2008, Radiology.

[103]  A. Hiltner,et al.  Vitamin E as an antioxidant for poly(etherurethane urea): in vivo studies. Student Research Award in the Doctoral Degree Candidate Category, Fifth World Biomaterials Congress (22nd Annual Meeting of the Society for Biomaterials), Toronto, Canada, May 29-June 2, 1996. , 1996, Journal of biomedical materials research.

[104]  N. Ziats,et al.  Effect of Intratumoral Injection of Carboplatin Combined with Pluronic P85 or L61 on Experimental Colorectal Carcinoma in Rats , 2007, Experimental biology and medicine.

[105]  T. Higuchi,et al.  Rate of release of medicaments from ointment bases containing drugs in suspension. , 1961, Journal of pharmaceutical sciences.

[106]  P. Shastri.  Toxicology of polymers for implant contraceptives for women. , 2002, Contraception.

[107]  H. G. Schild.  Poly(N-isopropylacrylamide): experiment, theory and application , 1992 .

[108]  M. Nekoomanesh,et al.  The effect of aliphatic esters on the formation and degradation behavior of PLGA-based in situ forming system , 2011 .

[109]  Ute Hoffmann,et al.  Drug Delivery Engineering Principles For Drug Therapy , 2016 .

[110]  A. Mikos,et al.  Injectable, in situ forming poly(propylene fumarate)-based ocular drug delivery systems. , 2007, Journal of biomedical materials research. Part A.

[111]  C. Raman,et al.  A model for drug release from fast phase inverting injectable solutions. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[112]  K. Parsons,et al.  In vitro comparison of mechanical and degradation properties of equivalent absorbable suture materials from two different manufacturers. , 2011, Veterinary surgery : VS.

[113]  E. Doelker,et al.  Towards elucidation of the drug release mechanism from compressed hydrophilic matrices made of cellulose ethers. II. Evaluation of a possible swelling-controlled drug release mechanism using dimensionless analysis. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[114]  A. McHugh,et al.  The effect of Pluronic on the protein release kinetics of an injectable drug delivery system. , 2003, Journal of controlled release : official journal of the Controlled Release Society.

[115]  Z. Ram,et al.  Gliadel® wafer in initial surgery for malignant glioma: long-term follow-up of a multicenter controlled trial , 2006, Acta Neurochirurgica.

[116]  K J Brodbeck,et al.  Phase inversion dynamics of PLGA solutions related to drug delivery. Part II. The role of solution thermodynamics and bath-side mass transfer. , 1999, Journal of controlled release : official journal of the Controlled Release Society.

[117]  L. Claes,et al.  In vitro biocompatibility of bioresorbable polymers: poly(L, DL-lactide) and poly(L-lactide-co-glycolide). , 1996, Biomaterials.

[118]  Mario Grassi,et al.  Mathematical modelling and controlled drug delivery: matrix systems. , 2005, Current drug delivery.

[119]  V. Musil,et al.  The wet phase separation: the effect of cast solution thickness on the appearance of macrovoids in the membrane forming ternary cellulose acetate/acetone/water system , 2002 .

[120]  I. Sivin,et al.  The performance of levonorgestrel rod and Norplant contraceptive implants: a 5 year randomized study. , 1998, Human reproduction.

[121]  M. McGirt,et al.  Use of Gliadel (BCNU) Wafer in the Surgical Treatment of Malignant Glioma: A 10-Year Institutional Experience , 2008, Annals of Surgical Oncology.

[122]  Jagdish Singh,et al.  Controlled release of a model protein lysozyme from phase sensitive smart polymer systems. , 2004, International journal of pharmaceutics.

[123]  Kinam Park,et al.  Biodegradable Hydrogels for Drug Delivery , 1993 .

[124]  P. Parikh,et al.  Brain tumor and Gliadel wafer treatment. , 2011, Indian journal of cancer.

[125]  J. Rodriguez,et al.  Biocompatibility of a biodegradable in situ forming implant system in rhesus monkeys. , 1999, Journal of biomedical materials research.

[126]  Brent D. Weinberg,et al.  Model simulation and experimental validation of intratumoral chemotherapy using multiple polymer implants , 2008, Medical & Biological Engineering & Computing.

[127]  Allan S. Hoffman,et al.  Applications of thermally reversible polymers and hydrogels in therapeutics and diagnostics , 1987 .

[128]  R. Langer,et al.  Implantable controlled release systems. , 1983, Pharmacology & therapeutics.

[129]  Jagdish Singh,et al.  Phase-sensitive polymer-based controlled delivery systems of leuprolide acetate: in vitro release, biocompatibility, and in vivo absorption in rabbits. , 2007, International journal of pharmaceutics.

[130]  H. Ravivarapu,et al.  Sustained suppression of pituitary-gonadal axis with an injectable, in situ forming implant of leuprolide acetate. , 2000, Journal of pharmaceutical sciences.

[131]  R. Kapil,et al.  Development and Evaluation of In Situ Gel-forming System for Sustained Delivery of Insulin , 2011, Journal of biomaterials applications.

[132]  Luis Solorio,et al.  Noninvasive characterization of in situ forming implants using diagnostic ultrasound. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[133]  W. Saltzman,et al.  Pharmacokinetics of the Carmustine Implant , 2002, Clinical pharmacokinetics.

[134]  J. Siepmann,et al.  Mathematical modeling of bioerodible, polymeric drug delivery systems. , 2001, Advanced drug delivery reviews.

[135]  Liqun Zhang,et al.  Novel percolation phenomena and mechanism of strengthening elastomers by nanofillers. , 2010, Physical chemistry chemical physics : PCCP.

[136]  H. Leuenberger,et al.  Percolation theory — a novel approach to solid dosage form design , 1987 .

[137]  Remko M. Boom,et al.  Microstructures in phase-inversion membranes. Part I. Formation of macrovoids , 1992 .

[138]  Nidhi Mishra,et al.  Polymers in Drug Delivery , 2016 .

[139]  U. Hamper,et al.  Norplant implants: sonographic identification and localization for removal. , 1995, AJR. American journal of roentgenology.

[140]  A. Dash,et al.  Therapeutic applications of implantable drug delivery systems. , 1998, Journal of pharmacological and toxicological methods.

[141]  A Hatefi,et al.  Biodegradable injectable in situ forming drug delivery systems. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[142]  S. Venkatraman,et al.  Effect of Polymer Type on the Dynamics of Phase Inversion and Drug Release in Injectable In Situ Gelling Systems , 2012, Journal of biomaterials science. Polymer edition.